B cells do not take up bacterial DNA: An essential role for antigen in exposure of DNA to toll-like receptor-9 by Roberts, Tara L. et al.
This article is published as: 
 
Roberts, T.L., Turner, M.L., Dunn, J.A., Lenert, P., Ross, I.L., Sweet, M.J., Stacey, K.J. (2011) B 
cells do not take up bacterial DNA: An essential role for antigen in exposure of DNA to toll-like 
receptor 9. Immunology and Cell Biology 89:517-525.  
doi: 10.1038/icb.2010.112
B cells do not take up bacterial DNA: An essential role for antigen in exposure of DNA to 
TLR9 
Tara L. Roberts*†, Marian L. Turner‡, Jasmyn A. Dunn*§, Petar Lenert¶, Ian L. Ross*, Matthew 
J. Sweet*, Katryn J. Stacey*§ 
* The University of Queensland, Institute for Molecular Bioscience, QLD 4072 Australia, 
† The Queensland Institute of Medical Research, Brisbane, QLD 4029 Australia, 
‡ Walter and Eliza Hall Institute of Medical Research, Parkville, Victoria 3052 Australia 
§ The University of Queensland, School of Chemistry and Molecular Biosciences, QLD 4072, 
Australia,  
¶ Department of Internal Medicine, Carver College of Medicine, The University of Iowa, Iowa 
City, IA 52242 USA,  
 
Running Title: B cell uptake of bacterial DNA depends on antigen. 
 
Corresponding Author: Katryn Stacey, The University of Queensland, School of Chemistry and 
Molecular Biosciences, St Lucia QLD 4072, Australia,  
Tel +61 7 33462087;    Fax +61 7 33462101; Email: katryn.stacey@uq.edu.au
Abstract 
Murine dendritic cells (DC) and macrophages respond to bacterial CpG DNA through TLR9. 
Although it is frequently assumed that bacterial DNA is a direct stimulus for B cells, published 
work does not reliably show responses of purified B cells. Here we show that purified splenic B 
cells did not respond to E. coli DNA with induction of CD86, despite readily responding to single 
stranded (ss) phosphodiester CpG oligodeoxynucleotides (ODN). This was due to a combination 
of weak responses to both long and double stranded (ds) DNA. B cell DNA uptake was greatly 
reduced with increasing DNA length. This contrasts with macrophages where DNA uptake and 
subsequent responses were enhanced with increasing DNA length. However, when DNA was 
physically linked to hen egg lysozyme (HEL), HEL-specific B cells showed efficient uptake of 
DNA, and limited proliferation in response to the HEL-DNA complex. We propose that, in the 
absence of other signals, B cells have poor uptake and responses to long dsDNA to prevent 
polyclonal activation. Conversely, when DNA is physically linked to a B cell receptor (BCR) 
ligand, its uptake is increased, allowing TLR9-dependent B cell activation in an antigen-specific 
manner. We could not generate fragments of E. coli DNA by limited DNaseI digestion that could 
mimic the stimulatory effect of ss CpG ODN on naïve B cells. We suggest that the frequently 
studied polyclonal B cell responses to CpG ODN are relevant to therapeutic applications of 
phosphorothioate-modified CpG-containing ODN, but not to natural responses to foreign or host 
ds DNA. 
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Introduction 
Unmethylated CG dinucleotides (CpG motifs) in DNA are recognised as foreign, and stimulate 
innate immune responses through toll-like receptor 9 (TLR9).1,2 Mouse B cells1, macrophages3 
and dendritic cells (DCs)4 are reported to respond to CpG DNA. TLR9 is a member of a subset of 
the TLR family (TLR3, TLR7, TLR8 and TLR9), which recognise foreign nucleic acids and are 
generally located on intracellular membrane compartments. If cells are to respond to extracellular 
DNA via intracellular TLR9, DNA uptake mechanisms are clearly required. Thus DNA uptake is 
a point at which TLR9 responses can be regulated or restricted. In myeloid cells, TLR9 localises 
to the endoplasmic reticulum and moves to meet DNA-containing endosomes.5-8 In resting B 
cells, TLR9 colocalised with early endosomal markers.9 Ligation of the B cell receptor (BCR) led 
to recruitment of TLR9 to an intracellular MHCII loading compartment, to which the BCR 
delivers antigen.9 This facilitates the TLR9-mediated recognition of DNA within antigen 
complexes. 
 
The role of mouse B cell TLR9 in promoting autoantibody production has been intensively 
studied.10-12 BCR-mediated uptake of complexes containing DNA results in synergistic signalling 
involving both the BCR and TLR9, which promotes B cell proliferation.10,12 Efficient cellular 
activation by antigen-TLR ligand complexes is thought to explain the fact that in the autoimmune 
condition systemic lupus erythematosus (SLE) many autoantibodies target DNA, or proteins 
which associate with DNA and RNA. The targeted delivery of DNA to TLR9 via BCR-mediated 
uptake may cause accumulation of enough poorly stimulatory self DNA to allow a TLR9 
response. In addition, in SLE there can be elevated circulating interferon-α which further 
enhances responses to weak TLR9 agonists in B cells.11 
 
Studies on TLR9 now predominantly use phosphorothioate-stabilised CpG ODN, and frequently 
assume that these synthetic single stranded ODN will mimic the biological effect of bacterial or 
viral DNA. The nuclease resistance of phosphorothioate ODN means that they are more potent in 
vivo than bacterial DNA,13 and they also show higher cellular uptake than ODN with a natural 
backbone.14 Furthermore, we found that the reported species differences in the optimal flanking 
sequences of the CpG motif required for TLR9-dependent responses actually only applies to 
phosphorothioate ODN.15 Phosphorothioate ODN also show a degree of CpG-independent 
activation of B cells.16,17 DNA structure, on the other hand, can also affect TLR9 responses. 
Increasing DNA length improved macrophage DNA uptake and subsequent responses.18 Double 
stranded DNA was also more potent in macrophage activation.18 Therefore, studies aiming to 
understand normal biological responses to CpG DNA should use naturally occurring DNA and 
not exclusively synthetic ODN. 
 
Bacterial DNA has a much higher frequency of stimulatory CpG motifs than mammalian DNA,19 
and there is a common perception that bacterial DNA is a strong polyclonal B cell mitogen. 
Whilst, mouse naïve B cells are viewed as responding polyclonally to TLR9 ligands, human 
naïve B cells are proposed to have antigen-specific TLR9 responses20 as their expression of 
TLR9 is low until they are stimulated through the BCR.21,22 There is no doubt that synthetic 
phosphorothioate-stabilised CpG ODN are a powerful polyclonal stimulus for B cells,23-25, but 
two reports using highly purified mouse B cells failed to find direct stimulation of proliferation 
and antibody production by bacterial DNA.26,27 Another study suggested that human B cells were 
insufficiently sensitive to E. coli DNA for it to elicit polyclonal responses in a physiological 
setting.28 Polyclonal B cell activation can occur during infections, but an overwhelming response 
is not to the benefit of the host. Work presented here demonstrates that natural DNA alone does 
not contribute to polyclonal activation, because naïve B cells are not able to take up bacterial 
DNA. B cell TLR9 appears to be engaged by natural DNA only when the DNA is associated with 
antigen taken up through the BCR, and will therefore only enhance antigen-specific responses. 
Our work clarifies the common misconception that bacterial DNA is a polyclonal mitogen for 
mouse B cells, and provides insight into likely B cell TLR9 functions in the host response to 
pathogen challenge. 
Results 
WEHI231 cells respond to CpG ODN but not E. coli DNA. 
Our previous work showed that in macrophages and dendritic cells, DNA uptake and subsequent 
response to CpG motifs increased with DNA length.18 However, increasing the length of DNA 
did not enhance uptake in L929 fibroblasts or two B cell lines.18 We therefore questioned whether 
B cells have efficient responses to long bacterial DNA. WEHI231 is an immature B cell line 
known to respond to CpG-containing ODN.29,30 WEHI231 cells were treated with a 44 base CpG 
phosphodiester ODN or E. coli DNA for 24h and supernatants were assayed for production of IL-
6. IL-6 production was readily detectable in response to 3µg/ml of the CpG-containing ODN LO, 
but unexpectedly, no IL-6 was detected from treatment with up to 50µg/ml E. coli DNA (Figure 
1A). The two most obvious structural differences between ODN and bacterial DNA are length 
and strandedness. To assess the effect of strandedness, the stimulatory ODN LO was made ds. 
This completely prevented activity at concentrations up to 50µg/ml. Thus in this cell line, ds 
DNA is apparently non-stimulatory. However, strandedness is unlikely to be the only factor 
preventing responses to E. coli DNA, as boiled E. coli DNA was similarly inactive (Figure 1A). 
In contrast to these findings in WEHI231 cells, E. coli DNA and dsLO both readily stimulated 
IL-6 production from bone marrow-derived macrophages (BMM) as expected (Figure 1B). In 
BMM, similarly to the RAW264 cell line,18 ds ODN were more potent than ss ODN, perhaps 
because of improved uptake18 and stability.  
 
Purified splenic B cells have limited responses to double-stranded and long DNA. 
To confirm whether the non-responsiveness of WEHI231 cells to E. coli DNA was reflective of 
primary B cells, we purified murine splenic B cells. B cells were negatively selected by depleting 
all CD43 positive cells from mixed splenocytes, leaving a population of marginal zone and 
follicular B cells that were more than 95% CD19 positive (Figure 2A). The response of B cells to 
E. coli DNA and ODN was measured by upregulation of the co-stimulatory marker CD86. This 
flow cytometric assessment allowed us to be sure that the population as a whole were responding, 
whereas an ELISA assay for cytokine may detect activation of a subpopulation or a 
contaminating population. In addition, upregulation of CD86 is likely to be a sensitive measure 
for a response to CpG DNA, since the requirements for induction of B cell CD86 expression are 
less stringent than those for proliferation; purified naïve B cells were reported to respond to CpG 
ODN with induction of CD86, although they required collaborating signals such as CD40L or T 
cell products in order to proliferate.22,31 Similarly to WEHI231 cells, purified splenic B cells 
responded to ss CpG ODN, but not E. coli DNA (Figures 2B and C). Responses to the ss ODN 
occurred in a polyclonal manner, as can be seen from raw flow cytometry data (Figure 2B) 
therefore data is presented as mean fluorescence intensity for CD86 staining for the entire 
population. DNA strandedness and length were considered as explanations for the inactivity of E. 
coli DNA on primary B cells.  
 
Although the effect was not as absolute as in the WEHI231 cell line, double strandedness was 
clearly unfavourable for activation of splenic B cells. A response to the ds phosphodiester ODN 
1668 was only detected at 10µM (equivalent to 60µg/ml of active strand for 1668) (Figure 2D). 
No activity of the GC inversion of 1668 was observed, as expected for responses mediated by 
TLR9. The complementary sequence to 1668 (1668R), which does not contain a canonical CpG 
motif (G/AACGTT), was similarly inactive. Apart from strandedness, length was also a factor 
since the 22mer 1668 was much more potent than the 44mer LO in upregulating CD86 in splenic 
B cells (Figure 2E). This was not due to suboptimal flanking sequences in LO, since in 
macrophages the direct reverse was seen, with LO being dramatically more active than the 
shorter 1668.18 The poor B cell responses to the 44mer ODN LO declined still further when the 
ODN was made ds (Figure 2E). Thus, both double strandedness and DNA length are likely to 
contribute to the lack of activity of E. coli DNA on purified B cells. As a corollary of this, it 
could be argued that B cell responses to E. coli DNA should emerge if the DNA was sheared and 
denatured. The length of the DNA appeared to be critical as freshly boiled E. coli DNA was also 
inactive in primary B cells (Figure 2F). However even when DNA was cleaved to a size range of 
20-250bp by limited DNaseI digestion (Supplementary Figure 1) and denatured, it was still 
unable to measurably activate primary B cells (Figure 2F). This is probably largely due to the 
limited range of DNA size to which B cells respond (i.e. effective responses to 22 base CpG 
ODN but poor responses once DNA reaches 44 bases shown in Figure 2E). DNaseI digestion of 
DNA, which introduces single strand nicks and double strand breaks, could not necessarily yield 
sufficient concentration of DNA within the appropriate size range. In addition, the frequency of 
CpG motifs in the degraded E. coli DNA is not so great as in the 1668 ODN, adding to the 
inefficiency of B cell recognition of CpG sequences within natural DNA. 
 
Limited uptake of long DNA limits B cell responses. 
A limiting step in macrophage responses to TLR9 ligands is DNA uptake, and increased uptake 
of long ODNs by BMM correlated with their greater potency.18 We examined whether 
restrictions on DNA uptake were affecting the pattern of response of purified B cells. B cells 
were incubated with Cy3-labelled ODN for 1h and DNA uptake was measured by flow 
cytometry. B cell uptake of the shorter ODN 1668 was up to 4-fold greater than the uptake of LO 
(Figure 3A). Thus, the low uptake of longer ODNs would limit B cell responses to these agonists. 
 
The possibility that poor uptake is responsible for the lack of activity of E. coli DNA in B cells 
was investigated by comparing the uptake of linearised plasmid DNA and short ODN in B cells 
and BMM. Plasmid DNA was used in order to have DNA of a defined length and degree of 
labelling per molecule, rather than using E.coli DNA which is partially sheared. B cell and BMM 
uptake of the short ODN 1668 was readily detectable. BMM uptake of ODN 1668 was linear 
with concentration up to 10µg/ml, consistent either with pinocytotic uptake, or uptake by a 
receptor which is either abundant or of low affinity, and therefore not saturated at the 
concentrations used (Figure 3B). Consistent with our previous results in macrophages showing 
length-dependent uptake,18 plasmid DNA accumulated efficiently in BMM, but uptake was 
barely detectable in primary B cells (Figure 3C). In B cells the major route for taking up foreign 
material is via the BCR. Previous studies have suggested that optimal B cell activation by CpG 
DNA requires linkage to antigen.10,23 We next determined whether in our hands DNA 
conjugation to antigen was a requirement for B cell responses to plasmid DNA. 
 
B cell responses to DNA:antigen complex 
Complexes were prepared by biotin-labelling both HEL and plasmid DNA, with addition of 
neutravidin. HEL was labelled with approximately one biotin per molecule, and plasmid with an 
estimated 30 biotin residues. Figure 4A shows the formation of complexes assessed by agarose 
gel electrophoresis, when neutravidin and HEL were bound in increasing amounts to plasmid 
DNA. The fastest migrating supercoiled plasmid form was retarded upon formation of the 
protein-DNA complex, and some formation of much larger complexes is indicated by increasing 
amounts of plasmid in the well. Mixing of DNA and HEL without addition of neutravidin caused 
no alteration in DNA migration. 
 
We sought to confirm that a complex of DNA and antigen gives efficient B cell proliferation 
using our prepared complexes. A pure population of HEL-specific splenic B cells was isolated 
from SWHELRAG2-/- mice and labelled with CFSE. Cells were stimulated with DNA:HEL 
complex or DNA mixed with HEL at a molar ratio of 1:10, and harvested after 2, 3 and 4 days of 
culture to examine cell division by dilution of CFSE label. Cells which did not stain with 
propidium iodide were selected as the viable population for analysis of proliferation 
(Supplementary Figure 2). There was no division of cells treated with HEL alone, 
HEL:neutravidin complex, DNA alone, DNA:neutravidin complex or HEL mixed with DNaseI-
digested DNA to control for impurities (data not shown). At day 2 of treatment with DNA mixed 
with HEL there was a slight shoulder on the CFSE profile, showing very limited replication 
(Figure 4B). Cells treated with the DNA:HEL complex showed a clearer indication of a 
population of cells which had undergone one round of division at day 2 (Figure 4C). Only a 
minority of cells survived and responded to these treatments, although the majority of the cells 
proliferated in response to the phosphorothioate-stabilised CpG ODN 1668S (Figure 4D and 
Supplementary Figure 2). By day 3, clear proliferation could be seen in the small number of 
surviving cells in the sample treated with DNA:HEL complex (Figure 4E), but insignificant 
numbers of cells treated with the DNA+HEL mixture survived (Supplementary Figure 2). These 
results contrast with the robust replication and expansion of cell numbers seen when cells were 
exposed to the ODN 1668S (Figure 4E and Supplementary Figure 2). In summary, there was 
clear evidence for proliferation of a limited number of cells exposed to DNA:HEL complex, but 
this was not sustained and most cells were dead after 4 days.  
 
The relatively poor ability of the HEL:DNA complex to sustain survival and proliferation was 
surprising given the potent response to a single agent, the phosphorothioate CpG ODN. We 
considered whether the biotinylation of the plasmid DNA could affect its ability to stimulate 
TLR9. The activities of plasmid and biotinylated plasmid were compared using a macrophage 
cell line with stably integrated NF-κB-dependent reporter.19 Supplementary Figure 3 shows that 
biotinylation did not affect TLR9 recognition of plasmid CpG motifs. DNase digestion confirmed 
that the macrophage response was due to plasmid DNA and not a contaminant. 
 
B cells take up DNA in complex with antigen 
No previous work has assessed the impact of linking antigen to bacterial DNA on its cellular 
uptake. We examined this using complexes prepared with plasmid labelled with both biotin and 
Cy3 (Figure 4A). HEL-specific splenic B cells were exposed to a fixed amount of labelled 
plasmid, with increasing amounts of HEL either directly linked to the plasmid, or just mixed with 
the plasmid. The uptake of DNA-HEL complexes into primary HEL-specific B cells was strongly 
dependent on the number of HEL molecules linked to each plasmid molecule (Figure 5). A large 
improvement in uptake was seen when the ratio of DNA to HEL was increased from 1:1 to 1:3, 
and uptake reached a maximum at a ratio of 1:20. The uptake of DNA alone or DNA linked to 
neutravidin at a 1:30 ratio (“D:N”) was undetectable. Unexpectedly, mixing HEL and DNA, 
without addition of neutravidin to link the two, gave low but detectable DNA uptake, correlating 
with the small amount of proliferation seen under these treatment conditions (Figure 4B). This 
low level of uptake suggests either that BCR ligation and signalling induces a mechanism 
allowing limited uptake of long DNA, or that HEL and DNA interact independently of the biotin-
dependent association. As a control, B cells were also isolated from C57BL/6 mice, and these 
showed no uptake of HEL:DNA complexes. Uptake of Cy3-labelled 1668 ODN is shown to 
confirm that the C57BL/6 B cells were viable. This data suggests that murine B cells only 
internalise long ds DNA if it is presented in combination with an antigen that can engage the 
BCR. 
 
Discussion  
DNA or DNA-containing complexes must undergo endocytic uptake in order to activate TLR9, 
since this receptor is localized in endosomal compartments. Expression of the costimulatory 
marker CD86 on purified primary follicular and marginal zone B cells was induced by 
phosphodiester CpG ODN but not E. coli DNA (Figure 2C). This was explained by lack of 
appreciable uptake of long DNA molecules. These results contrast with the widespread 
perception that B cells respond polyclonally to bacterial DNA. The ability of B cells to take up 
oligonucleotides but not long DNA molecules contrasts with macrophages, where long DNA is 
taken up more efficiently and is a more potent stimulus.18 However, plasmid DNA was 
internalised by B cells when complexed with an antigen recognized by the BCR. BCR-mediated 
uptake of antigen:DNA complexes evidently overcomes the limitations on DNA length for 
uptake; B cells can take up particles up to at least 0.5µm diameter linked to antigen.32 Long 
foreign DNA within DNA-antigen complexes is likely to enhance activation of B cells in an 
antigen-specific manner, and have no non-specific polyclonal effect. The polyclonal activation of 
B cells widely reported with phosphorothioate-modified CpG ODN may have no relevance to the 
normal B cell response to infection.  
 
In parallel with the greatly improved uptake of DNA when complexed to HEL, we found that 
such complexes were able to elicit proliferation of HEL-specific B cells, whereas DNA or HEL 
alone had no effect. Similar results have been seen with HEL and CpG ODN bound to beads, 
where there was no uptake or response unless HEL and CpG ODN were bound on the same 
beads.32 Furthermore, Uccellini et al.11 found that with physiologically relevant concentrations of 
DNA, bacterial and other DNAs longer than 50bp only promoted B cell proliferation when 
physically linked to an antigen recognised by the BCR. Our work has shown that this is explained 
by the lack of uptake of uncomplexed long bacterial DNA. The same study11 showed a minor 
amount of proliferation in B cells from C57BL/6 mice in response to E. coli DNA alone. This 
was attributed to the low but finite frequency of cells in the normal repertoire that possess BCRs 
directly recognising DNA, since it was not seen in B cells with transgenic BCR11. A number of 
previous reports have shown mouse B cell proliferation in response to bacterial DNA,1,33-35 and 
some may have similarly been measuring responses of cells with DNA-specific BCRs. Most 
studies have also been done on unpurified or partially purified splenocytes that may contain other 
B cell subsets with greater responses to bacterial DNA. Alternatively, bacterial DNA may trigger 
the production of cell surface or secreted molecules from other cell types, which then directly 
activate B cells or alter the threshold for B cell activation. A previous study showed production of 
IgM by mixed splenocytes but not purified B cells in response to bacterial DNA, suggesting a 
role for paracrine factors.36 A further complication is the lack of control for purity of bacterial 
DNA in some studies. 
 
The importance of BCR-mediated uptake of DNA-containing complexes and delivery of DNA to 
TLR9 has been studied extensively in the context of SLE,10-12,23 and the requirement for TLR9 in 
these responses has been established.11,23 This process is viewed as a way that chromatin debris, 
with a low frequency of CpG motifs, can accumulate to sufficient levels to stimulate TLR9 and 
contribute to autoantibody production. The lack of general B cell uptake of purified DNA we 
observed here has not been previously reported. It suggests that BCR-mediated antigen-DNA 
uptake is not only required for B cell responses to poorly stimulatory self DNA but is also 
necessary for effective responses to a strong TLR9 ligand, bacterial DNA. In vivo other routes 
may also contribute to enhanced B cell DNA uptake and responses. Recent work found that 
complex formation between DNA and the cationic antimicrobial peptide LL-37 increased B cell 
responses to E. coli DNA.37 
 
We observed that coadministration of unlinked HEL and DNA increased B cell uptake of long 
DNA, but not to the same extent as HEL linked to DNA. One explanation for our observations is 
that HEL associates with DNA and mediates DNA uptake. HEL is a basic protein with a pI of 
10.7, and an ability to bind DNA under physiological conditions.38 Our findings suggest that the 
DNA-binding ability of HEL should be taken into account in studies investigating requirements 
for B cell activation with HEL-specific BCR. This is especially relevant since even self DNA 
from spent culture medium has been shown to contribute to activation of B cells via TLR9.10 
Another possibility is that BCR ligation stimulates the cell to increase DNA uptake. Published 
work showed no effect of BCR ligation on the uptake of FITC-dextran,39 suggesting that an 
increase in non-specific pinocytosis is unlikely to explain the effect of HEL on DNA uptake. 
However, a recent study has shown that stimulation of B cells with a protein immune complex 
recognised through the BCR acted synergistically with unlinked CpG DNA of 600bp to promote 
some B cell proliferation.40 Hence it is possible that BCR ligation can specifically enhance DNA 
uptake, in order to allow B cells that have recognised antigen to actively survey their 
environment for PAMPs. 
 
Despite efficient uptake of the HEL-DNA complex, HEL-specific B cells proliferated in only a 
limited fashion in response to the plasmid-containing complex. A small proportion of cells 
formed B cell blasts, and these lost viability by the fourth day of treatment. It is possible that 
linkage of HEL to a whole bacterial genome would give a more potent stimulus due to uptake of 
a greater total length of DNA. Treatment with a phosphorothioate CpG ODN alone gave a more 
robust proliferative response, but these cells also started losing viability by Day 4. This is 
consistent with earlier work showing the proliferative response to CpG ODN was not so 
sustained as the response to other polyclonal activators.41 Experiments in vivo have shown that 
particulate complexes of antigen and CpG ODN elicited a short lived response with 
differentiation of B cells to extrafollicular plasma cells peaking at day 3 after stimulation.32 The 
full proliferation and differentiation of human naïve B cells is proposed to require three signals - 
BCR ligation, T cell help and TLR stimulation.42 With BCR ligation and either TLR stimulation 
or T cell help, cells initiated proliferation but viability was not maintained.42 It is likely that 
inputs from a number of sources such as antigen avidity, TLR ligation, T cell help, and cytokine 
environment can all contribute to pushing B cells over the activation threshold. The in vivo 
contribution of T cell-independent B cell activation via BCR and TLR signalling to generation of 
autoantibodies or protective antibodies early in infection remains to be fully established, but 
some work shows that generation of extrafollicular autoantibody producing cells required TLR 
stimulation but did not require T cells.43 
 
The most common TLR9 ligands used in the literature are phosphorothioate-modified ODN. 
These are powerful stimuli, and their study is relevant to therapeutic concerns. However results 
obtained with these stabilised ODN, and even with phosphodiester ODN, cannot be inferred to 
reflect responses to natural DNA. In an infection, B cells are likely to encounter DNA either as 
long molecules within viruses, or as a complex with bacterial proteins, released from damaged 
bacteria. Antigenic particulate material is presented to B cells on the surface of macrophages 
lining the subcapsular sinus in the lymph nodes.44,45 Some degradation of bacterial DNA in the 
extracellular environment via DNaseI could be expected. Here we used limited DNaseI digestion 
with or without denaturation, in order to see if degraded bacterial DNA would be able to activate 
B cells like ODN. We were unable to detect any effect of the partially degraded DNA, probably 
due to the very limited DNA size range taken up by B cells and the lower frequency of CpG 
motifs in bacterial DNA than in CpG ODN. Degradation of DNA allowing autonomous B cell 
responses to free bacterial DNA is thus unlikely to occur in vivo. We therefore question the 
biological relevance of responses to short single stranded phosphorothioate-modified ODN which 
are powerful B cell activators in the absence of other stimuli. In addition, we observed that B cell 
responses were not efficiently elicited by dsDNA ODN (Figure 2). Many workers routinely boil 
bacterial DNA for eliciting TLR9 responses, but there is unlikely to be a mechanism in vivo 
which would cause large scale denaturation of extracellular foreign DNA. 
 
This work has clearly shown that TLR9 responses in B cells are critically controlled by low 
uptake of long DNA. This barrier can be overcome if DNA is part of a complex recognised by the 
BCR. Thus in natural infections, foreign DNA may promote antibody responses to closely 
associated foreign antigens. The often-studied phenomenon of B cell activation by short CpG 
ODN may have little biological relevance, except in the context of therapeutic applications.
Methods 
Cell Culture 
RPMI 1640 containing 10% FCS (Gibco), 2mM L-glutamine, 100U/ml penicillin and 100µg/ml 
streptomycin was used for culture of primary macrophages. FCS was screened for low basal 
activation of macrophages and optimal CpG DNA responses. Primary B cells were grown in the 
above medium with addition of 10mM HEPES buffer, 0.1mM non-essential amino acids, 1mM 
sodium pyruvate and 50µM 2-mercaptoethanol. WEHI231 culture medium also contained 10mM 
HEPES buffer, 1mM Sodium Pyruvate and 50µM 2-mercaptoethanol. WEHI231 cells were a gift 
from David Tarlinton (Walter and Eliza Hall Institute, Melbourne, Australia). Bone marrow-
derived macrophages (BMM) were differentiated from the bone marrow of C57BL/6 mice as 
described previously.46 B cells were obtained from spleens of C57BL/6 mice or SWHELRAG2-/- 
mice. SWHEL mice, which express a HEL-specific BCR47 were originally provided by Robert 
Brink (Garvan Institute of Medical Research, Sydney). These were crossed with RAG2-/- mice to 
provide pure populations of B cells with HEL-specific BCR. All animal work was approved by 
University of Queensland or WEHI animal ethics committees and carried out according to 
institutional guidelines. Splenocytes were isolated as described previously.18 For DNA uptake 
studies, B cells were purified from splenocytes by negative selection using an antibody against 
CD43. Briefly, red blood cells were lysed in lysis buffer (150mM ammonium chloride, 10mM 
potassium hydrogen carbonate and 1mM disodium EDTA) and remaining cells incubated with 
CD43 MACS microbeads (Miltenyi Biotech) and then passed twice over an LD separation 
column. B cell purity was 95-98% as determined by CD19 staining. CD43- cells contain 
marginal zone and follicular B cells but not B1 or plasma cells48 or a sub-population of memory 
B cells.49 For B cell proliferation studies, cells were isolated by MACS with a preliminary percoll 
gradient step to enrich for small resting follicular B cells, as described.41 
 DNA and ODN 
The following ODN were synthesized with a phosphodiester backbone and were purchased from 
Geneworks (Adelaide, Australia). 
1668 5ʹ′-TCCATGACGTTCCTGATGCT-3ʹ′,50 1668R is complementary to 1668, 
LO 5ʹ′-GCCTTAGGGACTAGCTCATAACGTTCCTGATGCTGTAGAGTAGG-3ʹ′, 1668-GC 
5ʹ′-TCCATGAGCTTCCTGATGCT-3ʹ′. 1668S ODN has the same sequence as 1668, but has a 
phosphorothioate-modified backbone. Where use of dsODN is noted, ODN were made ds by 
addition of a complementary strand in PBS, heating at 60˚C for 5min, followed by slow cooling 
to room temperature. E. coli strain B DNA (Sigma) was purified using phenol chloroform 
extraction and ethanol precipitation followed by four extractions using Triton-X114 to remove 
LPS, phenol chloroform extraction and ethanol precipitation as described previously.19 Purity of 
DNA was confirmed by lack of macrophage stimulatory activity of DNaseI-digested DNA 
(Supplementary Figure 3). pBluescriptSK+ plasmid DNA was prepared using a Qiagen Endo-free 
maxiprep kit. Lack of LPS contamination of DNA was confirmed by examining stimulation of 
the NF-κB responsive reporter gene in ELAM9 cells,19 by complete DNaseI-digests of DNA 
samples. For denatured E. coli DNA, samples were placed on a 100°C heating block for 10min 
and then placed directly on ice before addition to cells. Small sized fragments of E. coli DNA 
were generated by limited digestion with DNaseI, then purified by phenol-chloroform extraction 
and ethanol precipitation (Supplementary Figure 1). Plasmid and genomic DNA from E.coli lacks 
the CpG methylation which interferes with TLR9 recognition. The two major bacterial 
methylases are Dam, which methylates adenine in GATC sequences and Dcm which methylates 
the second cytosine in CCA/TGG sequences, and these do not affect TLR9-mediated responses.18 
 
DNA Uptake 
The ODNs 1668 and LO were synthesized with a 5ʹ′ Cy3 label (Geneworks, Adelaide, Australia). 
Plasmid pBluescript SK+ was prepared by Qiagen endo-free maxiprep kit (Qiagen, GmbH, 
Germany). Plasmid was linearised with endonuclease EcoRV and purified by Triton X-114 
extraction as for E. coli DNA above. Linearised plasmid was labeled with Cy3 using a label IT 
tracker kit (Mirus, Madison, WI, USA). Efficiency of labeling of ODN and plasmid was 
estimated by measuring A260 and A550 and using a molar absorption coefficient of 150 000 for 
Cy3 at 550nm. 200 000 B cells/well were plated in 24 well plates in 500µl of complete medium, 
treated with various concentrations of labeled DNAs for the indicated times then harvested and 
washed with PBA (PBS + 0.1% sodium azide and 0.1% BSA). Cells were then incubated with 
100µg/ml DNaseI (Sigma) for 10 min at room temperature to remove any DNA bound to the cell 
surface. Cells were washed with PBA and then analysed by flow cytometry (FACS-calibur or 
FACScanto, Becton Dickinson). Results were corrected for a small difference in Cy3 labeling 
efficiency for different ODN.  
 
ELISA 
1x106 B cells/well were plated in 500µl in 24-well plates and treated with DNA for 24h. ELISA 
was performed using paired antibodies against mouse IL-6 (BD PharMingen) as described 
previously.51 
 
Cell surface marker staining 
150 000 B cells/well were plated in 200µl in 48-well plates and treated with DNA for 24h. Cells 
were harvested, washed in PBS, blocked in 1% FCS/PBA and then stained with either rat anti-
mCD19 (BD PharMingen), rat anti-mCD86 (eBioscience) or matching isotype controls for 1h. 
Cells were then washed twice with PBA and then analysed by flow cytometry with either a BD 
FacsCalibur or BD LSRII. These instruments have different dynamic ranges which affect the 
numerical output for fluorescence levels, but not the relative fluorescence levels between 
samples. Mean fluorescence intensity (MFI) is expressed in arbitrary units and absolute values 
are of no consequence. Analysis was performed using CellQuest (Version 3.1) (Becton 
Dickinson). 
 
Preparation of HEL-DNA complexes 
Complexes were prepared by covalent linkage of biotin to both HEL and DNA, and addition of 
neutravidin. For uptake studies, pBluescriptSK+ (pBS) was labeled with both biotin and Cy3 
using labelIT kits (Mirus). The extent of Cy3 labelling was assessed by measuring A550, and 
determined to be approximately 33 labels per plasmid. A similar amount of labeling by biotin 
was anticipated from use of equivalent amounts of labelling reagent. For proliferation studies, 
pBS was labeled only with biotin, at an estimated 20 labels per plasmid. TLR9 stimulatory 
activity of the biotinylated DNA was confirmed by using the NF-κB dependent reporter cell line 
ELAM9 as described previously.19 HEL was labeled with biotin using amine-reactive N-
hydroxysuccinimide biotin (Sigma), at a molar ratio of HEL:NHS-biotin of 1:1.7. The labelling 
was done for 3h in 50mM MES, pH6 to give preferential modification of the N terminal amine. 
HEL was determined to be more than 95% labeled, as determined by pull-down on streptavidin-
sepharose. Trial binding reactions using neutravidin (Pierce), which should have four biotin-
binding subunits, showed a maximum of 2-3 active binding sites per neutravidin tetramer. For 
preparation of complexes, biotin-pBS was mixed with biotin-HEL at various molar ratios in PBS 
with 0.5mg/ml BSA, prior to addition of neutravidin, which was added equimolar with the HEL. 
For uptake studies, the molar ratios of DNA:neutravidin:HEL ranged from 1:1:1 to 1:30:30. For 
B cell proliferation experiments, the molar ratio of DNA:neutravidin:HEL was 1:10:10. Control 
reactions omitting either one or two components of the complex were also prepared.  
 
Analysis of B cell proliferation 
Follicular B cells were isolated from SWHELRAG2-/- mice and stained with 10µM CFSE for 
10min at 37˚C. Cells were plated in 96 well plates at 20 000 cells per well, and incubated with 
HEL-DNA complexes or control 1668S for four days. Except for the 1668S-treated sample, each 
day 75% of the medium was replaced to ensure results were not compromised by DNA 
degradation. After 2, 3 and 4 days incubation, cells were harvested and stained with propidium 
iodide for flow cytometric analysis. Viable cells were gated for analysis of CFSE dilution. 
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Figure Legends 
Figure 1. The B cell line WEHI231 does not respond to long or ds CpG DNA. WEHI231 cells 
(A) or BMMs (B) were treated with indicated concentrations of either E. coli DNA, boiled E. coli 
DNA, ss CpG ODN (LO), or ds CpG ODN (dsLO) for 24h and then supernatants were assayed 
by ELISA for IL-6 production. Results are the average of duplicate treatments and error bars 
show the range of the duplicates. Results are representative of 2-3 independent experiments. 
 
Figure 2. Purified splenic B cells do not respond to E. coli DNA. A. Purity of negatively selected 
B cells as determined by CD19 expression. Isotype control staining – filled histogram, CD19 
staining - thick line. B-F. Purified B cells were incubated with indicated concentrations of DNA 
for 24h. Cells were then harvested, stained for the presence of cell surface marker CD86 and 
analysed by flow cytometry. MFI indicates mean fluorescence intensity of cells stained for CD86. 
The higher baseline values for MFI in panel F are of no consequence, and are due to use of a flow 
cytometer with different dynamic range (see methods). Relative changes in MFI are similar 
between instruments. In C-F, results show the average of duplicate treatments. Error bars, which 
may fall within the size of the symbol, indicate the range of the values within the experiment. 
Results are representative of three to four independent experiments for C-E and two experiments 
for F. B. B cells respond to 22 base ODN 1668, but not E. coli DNA. Overlays of flow cytometry 
data, filled histogram – stained untreated control, grey line – 50µg/ml E. coli DNA, black line – 
10µM 1668. C. Quantification of response to 22 base ODN 1668 and E. coli DNA. D. Effect of 
double strandedness on response to 1668. Cells were incubated with either 1668, ds1668, the 
complement of 1668 (1668R) or the GC inversion of 1668 (1668-GC). E. Short ODN are more 
immunostimulatory on B cells than long ODN. Cells were treated with 22 base CpG ODN 
(1668), 44 base CpG ODN (LO), ds 44 base CpG ODN (dsLO) or the GC inversion of 1668 
(1668-GC). F. Shearing with DNaseI (sEC), boiling (bEC) or both treatments (bsEC) of E. coli 
(EC) DNA does not make it stimulatory on primary B cells. DNA was treated with 2 different 
concentrations of DNaseI (0.02 or 0.03 U/µl) for 20 minutes, and the degree of digestion is 
shown in Supplementary Figure 1.  
 
Figure 3. B cells have poor uptake of long DNA. Uptake of Cy3-labelled DNA was analysed by 
flow cytometry. DNA uptake was uniform and dose-dependent in the populations and is 
expressed as mean fluorescence intensity (MFI). A. B cells were treated with the indicated 
concentration of Cy3-labelled ODNs, either 22 bases (1668) or 44 bases (LO) for 1h. Results 
were adjusted to account for slightly different efficiencies of labelling of ODN. B. BMM and 
purified B cells were treated with the indicated concentrations of Cy3-1668 for 2h. C. BMM and 
B cells were treated with the indicated concentrations of Cy3-linearised plasmid for 2h. Results 
are the average of duplicate treatments and the error bars indicate the range of the values within 
the experiment. Results are representative of three (A) or four experiments (B and C). 
 
Figure 4. Antigen-DNA complexes induce limited proliferation of B cells. A. The formation of 
Cy3 fluorescently labelled plasmid DNA-HEL complexes was assessed by the effect on plasmid 
migration in an agarose gel. Samples were DNA alone (D), DNA mixed with HEL at 1:30 molar 
ratio (D+H), or DNA-neutravidin-HEL conjugate (D:H). The ratios of DNA to HEL are 
indicated, and neutravidin was added in equimolar amounts to HEL in order to allow complex 
formation. The arrow indicates the supercoiled plasmid band which shows retarded migration 
with increasing amounts of bound HEL.  B-E. Proliferation of HEL-specific B cells in response 
to HEL:DNA complex was measured by CFSE dilution. Cells were left untreated, or stimulated 
with either HEL mixed with DNA (HEL + DNA), HEL-DNA conjugate or 1µM 1668S. The 
HEL-DNA conjugate was prepared at a molar ratio of DNA:neutravidin:HEL of 1:10:10. The 
final concentration of HEL in incubations was 33ng/ml, and DNA was 0.45µg/ml. DNA was not 
Cy3-labelled in these experiments. Results shown are CFSE dilution within the viable cell 
population analysed by flow cytometry, and represent all the treatments where there was any 
degree of proliferation. B. Effect of HEL mixed with DNA after 2 days incubation. C. Effect of 
HEL-DNA conjugate after 2 days incubation. D. Effect of 1668S after 2 days incubation. E. 
Effect of HEL-DNA conjugate and 1668S after 3 days incubation, compared to untreated sample 
from day 2. 
 
Figure 5. Linking plasmid DNA to antigen allows B cell DNA uptake. Uptake of HEL-DNA 
complexes by HEL-specific B cells. Cells were incubated for 1.75 hours with HEL-neutravidin 
(H:N), DNA alone (D), DNA-neutravidin (D:N) or the DNA-HEL conjugate (D:H) or DNA 
mixed with HEL (D+H) at various DNA:HEL molar ratios as indicated. The concentration of 
plasmid DNA in all incubations was 0.45 µg/ml. Cy3-labelled 1668 phosphodiester ODN (CpG) 
was used at 3µM as a control. Cy3-DNA uptake was measured by flow cytometry, and expressed 
as mean fluorescence intensity (MFI). Bars indicate the average of duplicate treatments and the 
error bars show the range of the values. Data is representative of 3 separate experiments. 
 
 
 
  
  
 
 





Supplementary Figures. 
 
Figure S1. Controlled digestion of E. coli DNA with DNase I. E. coli DNA was 
incubated with 0.02 or 0.03 units/µl of DNase I for 20min, then purified by phenol 
chloroform extraction and ethanol precipitation. Samples were analysed on a 2% 
agarose gel, and compared to undigested E. coli DNA and ds ODN of 44bp and 22bp. 
DNase digestion resulted in DNA products between approximately 20 and 250 bp in 
size. 
 
 Figure S2. Antigen-DNA complexes induce limited survival of B cells. In the 
experiment depicted in Figure 4B, cells were stained with propidium iodide (PI) and 
assessed on a plot of PI staining (y axis) vs forward scatter (x axis) to identify viable 
cells. Cells which were PI negative were gated as the viable population for analysis of 
CFSE dilution in Figure 4B. The sharp line at low FSC and low PI staining is due to 
beads which were added for quantification of cell number. As in Figure 4B, cells were 
either left untreated, or stimulated with either HEL alone, HEL-neutravidin complex, 
DNA alone, HEL mixed with DNA (HEL + DNA), HEL mixed with DNaseI-digested 
DNA, HEL-DNA conjugate or 1668S. Results are shown here for those samples 
which had enhanced cell survival and proliferation relative to untreated cells. The 
treatments in other samples had no detectable effect. The percentage of total cells 
falling in the gated viable region is indicated on each graph. 
 
 Figure S3. Biotinylation of plasmid DNA does not affect its TLR9-stimulatory 
activity. Biotinylated plasmid, as used to form DNA-HEL complexes in Figure 4B, 
was compared for TLR9-mediated activation to unmodified plasmid, using 
macrophage cells with a stably integrated NF-κB responsive GFP reporter (ELAM9 
cells19). Cells were incubated with 2µg/ml pBluescript (pBS), biotin-pBS or E. coli 
DNA for 6h. Digestion of plasmid with DNaseI confirmed the lack of stimulatory 
contaminants. The DNase control contained buffer and DNaseI but no DNA. GFP 
expression was analysed by flow cytometry. Bars show the average of duplicate 
treatments and the error bars show the range of the values.  
 
